{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:18:38Z","timestamp":1777951118492,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Michael J Fox Foundation for Parkinson Research"},{"name":"Envoy Therapeutics"},{"name":"NS 064439","award":["NIH R01"],"award-info":[{"award-number":["NIH R01"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.nbd.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T17:48:05Z","timestamp":1423072085000},"page":"67-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia"],"prefix":"10.1016","volume":"76","author":[{"given":"Sean Austin O.","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunmin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6849-6522","authenticated-orcid":false,"given":"Lisa","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"McGehee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-6839","authenticated-orcid":false,"given":"Un Jung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.01.003_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/exnr.2000.7362","article-title":"An altered histaminergic innervation of the substantia nigra in Parkinson's disease","volume":"163","author":"Anichtchik","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0015","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1523\/JNEUROSCI.14-06-03969.1994","article-title":"Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning","volume":"14","author":"Aosaki","year":"1994","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1152\/jn.1995.73.3.1234","article-title":"Temporal and spatial characteristics of tonically active neurons of the primate's striatum","volume":"73","author":"Aosaki","year":"1995","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.bjp.0703692","article-title":"Histamine depolarizes cholinergic interneurones in the rat striatum via a H(1)-receptor mediated action","volume":"131","author":"Bell","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0025","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1523\/JNEUROSCI.19-13-05586.1999","article-title":"Spontaneous activity of neostriatal cholinergic interneurons in vitro","volume":"19","author":"Bennett","year":"1999","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1600-0404.1974.tb02820.x","article-title":"Abnormal involuntary movements induced by anticholinergic therapy","volume":"50","author":"Birket-Smith","year":"1974","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2015.01.003_bb0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0306-4522(84)90165-9","article-title":"Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immunocytochemistry, Golgi-impregnation and electron microscopy","volume":"12","author":"Bolam","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.01.003_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1124\/jpet.108.140897","article-title":"Continuous and intermittent nicotine treatment reduces l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease","volume":"327","author":"Bordia","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2015.01.003_bb0045","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/jpet.109.162396","article-title":"Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization","volume":"333","author":"Bordia","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2015.01.003_bb0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0166-2236(99)01501-5","article-title":"Acetylcholine-mediated modulation of striatal function","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0055","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.01.003_bb0165","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1073\/pnas.181356498","article-title":"Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation","volume":"98","author":"Chartoff","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.01.003_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.09.017","article-title":"Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats","volume":"77","author":"Conti","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.01.003_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2007.03.013","article-title":"Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease","volume":"27","author":"Ding","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.003_bb0075","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.1006511108","article-title":"Enhanced striatal cholinergic neuronal activity mediates l-DOPA-induced dyskinesia in parkinsonian mice","volume":"108","author":"Ding","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.01.003_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2008.10.029","article-title":"Application of a translational profiling approach for the comparative analysis of CNS cell types","volume":"135","author":"Doyle","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.01.003_bb0085","doi-asserted-by":"crossref","first-page":"15340","DOI":"10.1523\/JNEUROSCI.3144-11.2011","article-title":"Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine","volume":"31","author":"Ellender","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.nbd.2012.07.012","article-title":"l-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function","volume":"48","author":"Espadas","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.003_bb0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.expneurol.2011.08.010","article-title":"Reduced striatal acetylcholine efflux in the R6\/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms","volume":"232","author":"Farrar","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2014.03.001","article-title":"Allosteric modulation of NMDA receptors alters neurotransmission in the striatum of a mouse model of Parkinson's disease","volume":"255","author":"Feng","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3949\/ccjm.78gr.11005","article-title":"Updates in the medical management of Parkinson disease","volume":"79","author":"Fernandez","year":"2012","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.nbd.2015.01.003_bb9000","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.1986.tb11123.x","article-title":"Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine","volume":"89","author":"Giachetti","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.20828","article-title":"Histamine H3 receptor agonists reduce l-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of Parkinson's disease","volume":"21","author":"Gomez-Ramirez","year":"2006","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2015.01.003_bb0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nn2052","article-title":"The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone","volume":"11","author":"Gras","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0120","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2015.01.003_bb0125","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/mds.21743","article-title":"Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa","volume":"22","author":"Hauser","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2015.01.003_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0031-6997(25)00039-0","article-title":"Distribution, properties, and functional characteristics of three classes of histamine receptor","volume":"42","author":"Hill","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2015.01.003_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2015.01.003_bb0140","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of l-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.23069","article-title":"Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease","volume":"25","author":"Johnston","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2015.01.003_bb0170","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1523\/JNEUROSCI.13-11-04908.1993","article-title":"Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum","volume":"13","author":"Kawaguchi","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0175","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1523\/JNEUROSCI.20-12-04405.2000","article-title":"Dopamine-deficient mice are hypersensitive to dopamine receptor agonists","volume":"20","author":"Kim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0155","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1073\/pnas.81.15.4998","article-title":"Tonically discharging putamen neurons exhibit set-dependent responses","volume":"81","author":"Kimura","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.01.003_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0306-4522(85)90049-1","article-title":"The cytoarchitecture, histochemistry and projections of the tuberomammillary nucleus in the rat","volume":"16","author":"K\u00f6hler","year":"1985","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.01.003_bb0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.003_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/syn.890150306","article-title":"Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models","volume":"15","author":"Martinez-Mir","year":"1993","journal-title":"Synapse"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2015.01.003_bb0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1994.sp020356","article-title":"Regulation of K+ conductance by histamine H1 and H2 receptors in neurones dissociated from rat neostriatum","volume":"480","author":"Munakata","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0225","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1523\/JNEUROSCI.0901-14.2014","article-title":"Striatal cholinergic neurotransmission requires VGLUT3","volume":"34","author":"Nelson","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mds.21235","article-title":"Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"22","author":"Nicholas","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.01.003_bb0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12640-009-9025-1","article-title":"Histaminergic activity in a rodent model of Parkinson's disease","volume":"15","author":"Nowak","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2015.01.003_bb0235","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","article-title":"Pitx3 is required for development of substantia nigra dopaminergic neurons","volume":"100","author":"Nunes","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.01.003_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4419-8056-4_10","article-title":"Histamine in neurotransmission and brain diseases","volume":"709","author":"Nuutinen","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with l-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2015.01.003_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870040301","article-title":"Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease","volume":"4","author":"Pourcher","year":"1989","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2015.01.003_bb0205","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s002109900097","article-title":"Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors","volume":"360","author":"Prast","year":"1999","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0255","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1471-4159.2002.00871.x","article-title":"Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy","volume":"81","author":"Rinne","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2015.01.003_bb0210","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson's disease prevents l-DOPA-induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2015.01.003_bb0265","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1523\/JNEUROSCI.0041-12.2012","article-title":"Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia","volume":"32","author":"Sciamanna","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(05)64001-9","article-title":"Section I. The cholinergic system","volume":"64","author":"Smythies","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.nbd.2015.01.003_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2014.09.010","article-title":"Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3 aphakia mice","volume":"73","author":"Solis","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.01.003_bb0280","first-page":"141","article-title":"Duration of amantadine benefit on dyskinesia of severe Parkinson's disease","volume":"75","author":"Thomas","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2015.01.003_bb0285","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2012.04.038","article-title":"Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons","volume":"75","author":"Threlfell","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.01.003_bb0290","first-page":"2535","article-title":"Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons","volume":"130","author":"Van den Munckhof","year":"2003","journal-title":"Dev. Camb. Engl."},{"key":"10.1016\/j.nbd.2015.01.003_bb0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.jhered.a107667","article-title":"Aphakia, a new mutation in the mouse","volume":"59","author":"Varnum","year":"1968","journal-title":"J. Hered."},{"key":"10.1016\/j.nbd.2015.01.003_bb0300","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1523\/JNEUROSCI.10-02-00508.1990","article-title":"Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum","volume":"10","author":"Wilson","year":"1990","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0305","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/mds.23034","article-title":"Long-term antidyskinetic efficacy of amantadine in Parkinson's disease","volume":"25","author":"Wolf","year":"2010","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2015.01.003_bb0310","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.2888-13.2014","article-title":"Striatal cholinergic cell ablation attenuates l-DOPA induced dyskinesia in Parkinsonian mice","volume":"34","author":"Won","year":"2014","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.nbd.2015.01.003_bb0315","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/jphysiol.2010.203257","article-title":"l-Dopa activates histaminergic neurons","volume":"589","author":"Yanovsky","year":"2011","journal-title":"J. Physiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115000157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T09:57:40Z","timestamp":1747562260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115000157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":60,"alternative-id":["S0969996115000157"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.01.003","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}